UK markets open in 5 hours 24 minutes

NIKKEI 225
37,894.36
-565.72(-1.47%)
HANG SENG
17,144.12
-57.15(-0.33%)
CRUDE OIL
82.72
-0.09(-0.11%)
GOLD FUTURES
2,330.10
-8.30(-0.35%)
DOW
38,460.92
-42.77(-0.11%)
Bitcoin GBP
51,757.76
-1,802.42(-3.37%)

The five essential pieces of financial paperwork you must never lose

Mislaying key documents can cause real headaches, so it’s worth tracking down these most commonly-lost bits of paperwork

GSK Jan 2025 32.000 put

OPR - OPR Delayed price. Currency in USD

Add to watchlist

0.5900

0.0000

(0.00%)

As of 09:30AM EDT. Market open.

Zacks
GSK (GSK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Glaxo (GSK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CityAM
US regulator accepts GSK’s application to expand treatment of cancer drug
The treatment, Jemperli, will now be classed as being able to help all adult patients with primary advanced or recurrent endometrial cancer. It is used alongside chemotherapy.
Fool.co.uk
Is this FTSE growth superstar set to soar even higher on new drug results?
New drugs should significantly boost this FTSE stock’s earnings in my view. But even without them it looked very undervalued to me. The post Is this FTSE growth superstar set to soar even higher on new drug results? appeared first on The Motley Fool UK.